<iframe src="http://www.npr.org/player/embed/6709305/6709306" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Read David Wessel's 'Wall Street Journal' column:
The controversial Medicare prescription drug benefit is a year old and seems to be a success. The Wall Street Journal's David Wessel talks with Renee Montagne about the program.
NPR thanks our sponsors
Become an NPR sponsor